within Pharmacolibrary.Drugs.ATC.A;

model A05BA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.04,
    Cl             = 1.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 150 / 1000000,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0013333333333333333,
    Tlag           = 1800
  );

  annotation(Documentation(
    info ="<html><body><p>Glycyrrhizic acid is the principal active constituent of licorice root (Glycyrrhiza glabra) and is known for its anti-inflammatory, hepatoprotective, and antiviral properties. It has been used in the treatment of chronic hepatitis and as a component in traditional medicine. It is not a first-line or widely approved drug in modern Western medicine but may still be used in certain countries as an adjunct in liver disorders.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic values estimated from available literature reviews and studies with healthy adult volunteers, oral administration.</p><h4>References</h4><ol><li><p>Shen, C, et al., &amp; Li, X (2021). Glycyrrhizic acid-based self-assembled micelles for improving oral bioavailability of paeoniflorin. <i>Drug development and industrial pharmacy</i> 47(2) 207–214. DOI:<a href=&quot;https://doi.org/10.1080/03639045.2020.1862178&quot;>10.1080/03639045.2020.1862178</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33305640/&quot;>https://pubmed.ncbi.nlm.nih.gov/33305640</a></p></li><li><p>Xu, B, et al., &amp; Zhang, G (2015). Comparative pharmacokinetics of puerarin, daidzin, baicalin, glycyrrhizic acid, liquiritin, berberine, palmatine and jateorhizine by liquid chromatography-mass spectrometry after oral administration of Gegenqinlian decoction and active components alignment (ACA) to rats. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 988 33–44. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2015.01.039&quot;>10.1016/j.jchromb.2015.01.039</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25746576/&quot;>https://pubmed.ncbi.nlm.nih.gov/25746576</a></p></li><li><p>Prakash Kamath, P, et al., &amp; Rathnanand, M (2024). Formulation and evaluation of ibrutinib-loaded glycyrrhizic acid conjugated ovalbumin nanoparticles and ibrutinib-glycyrrhizic acid complex for improved oral bioavailability. <i>Pharmaceutical development and technology</i> 29(10) 1185–1198. DOI:<a href=&quot;https://doi.org/10.1080/10837450.2024.2436190&quot;>10.1080/10837450.2024.2436190</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39642037/&quot;>https://pubmed.ncbi.nlm.nih.gov/39642037</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A05BA08;
